ELII: Broadly Specific Needle-Free Vaccines against Emerging and Biothreat Viruses

Project: Other project

Project Details

StatusFinished
Effective start/end date6/1/13 → 5/31/19

Funding

  • National Inst of Allergy & Infectious Di: $2,316,095.74